In addition, p53 impacts the immune recognition of tumor cells by regulating antigen presentation by MHC-I, as well as the expression of NKG2D ligands and PD-L1 via the transcriptional target miR-34a [106]. This evidence concerns the gene TP53 and neoplasm.